Marketing-authorisation holder · Belgium
Janssen-Cilag International N.V
353 medicines in 5 countries, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Belgium
353 medicines in 5 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 353
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Akeega | Niraparib, Abiraterone | EU (EMA) | Authorised | 2023 |
| AKEEGACompressa rivestita con film | Niraparib, Abiraterone | Italy | Authorised | |
| AKEEGA 100 MG/500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA159,40 mg + 500 mg · Comprimido recubierto con película | Niraparib, Abiraterone | Spain | Marketed | 2023 |
| Akeega 100 mg/500 mg filmomhulde tablettenFilmomhulde tablet | Abiraterone, Niraparib | Netherlands | Authorised | 2023 |
| AKEEGA 50 MG/500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA79,70 mg + 500 mg · Comprimido recubierto con película | Niraparib, Abiraterone | Spain | Marketed | 2023 |
| Akeega 50 mg/500 mg filmomhulde tablettenFilmomhulde tablet | Abiraterone, Niraparib | Netherlands | Authorised | 2023 |
| BALVERSACompressa rivestita con film | Erdafitinib | Italy | Authorised | |
| Balversa | Erdafitinib | EU (EMA) | Authorised | 2024 |
| BALVERSA 3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA3 mg · Comprimido recubierto con película | Erdafitinib | Spain | Marketed | 2024 |
| Balversa 3 mg filmomhulde tablettenFilmomhulde tablet | Erdafitinib | Netherlands | Authorised | 2024 |
| BALVERSA 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA4 mg · Comprimido recubierto con película | Erdafitinib | Spain | Marketed | 2024 |
| Balversa 4 mg filmomhulde tablettenFilmomhulde tablet | Erdafitinib | Netherlands | Authorised | 2024 |
| BALVERSA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA5 mg · Comprimido recubierto con película | Erdafitinib | Spain | Marketed | 2024 |
| Balversa 5 mg filmomhulde tablettenFilmomhulde tablet | Erdafitinib | Netherlands | Authorised | 2024 |
| BYANNLISospensione iniettabile a rilascio prolungato | Paliperidone | Italy | Authorised | |
| BYANNLI 1.000 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA1560 mg · Suspensión inyectable de liberación prolongada en jeringa precargada | Paliperidone | Spain | Marketed | 2022 |
| BYANNLI 1000 mg suspensie voor injectie met verlengde afgifteSuspensie voor injectie | Paliperidone | Netherlands | Authorised | 2021 |
| BYANNLI 700 mg suspensie voor injectie met verlengde afgifteSuspensie voor injectie | Paliperidone | Netherlands | Authorised | 2021 |
| BYANNLI 700 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA1092 mg · Suspensión inyectable de liberación prolongada en jeringa precargada | Paliperidone | Spain | Marketed | 2022 |
| Byannli (previously Paliperidone Janssen-Cilag International) | Paliperidone | EU (EMA) | Authorised | 2020 |
| CARIPULPolvere e solvente per soluzione per infusione endovenosa | Epoprostenol | Italy | Authorised | |
| Carvykti | Ciltacabtagene autoleucel | EU (EMA) | Authorised | 2022 |
| CARVYKTIDispersione per infusione | Ciltacabtagene autoleucel | Italy | Authorised | |
| Carvykti 0,15 - 1,0 x 10E8 cellen, dispersie voor infusieDispersie voor infusie | Ciltacabtagene autoleucel | Netherlands | Authorised | 2022 |
| CARVYKTI 3,2 × 10e6 - 1 × 10e8 CELULAS DISPERSION PARA PERFUSION3.2 x 10⁶ -1.0 x 10⁸ celulas · Dispersion para perfusion | Ciltacabtagene autoleucel | Spain | Marketed | 2022 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 144 | 138 | 6 | CompaniesAll medicines |
| Netherlands | 116 | 116 | 0 | CompaniesAll medicines |
| European Union (EMA) | 49 | 38 | 11 | CompaniesAll medicines |
| Italy | 37 | 37 | 0 | CompaniesAll medicines |
| Romania | 7 | 0 | 7 | CompaniesAll medicines |
Also in the registers of France
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.